2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
105
Carcinoma, Renal Cell
38
Leukemia, Myeloid, Acute
36
Neoplasm Metastasis
31
Neoplasms
22
Breast Neoplasms
22
Lymphoma, Non-Hodgkin
21
Kidney Neoplasms
20
Leukemia
18
Carcinoma, Non-Small-Cell Lung
18
Skin Neoplasms
17
Neuroblastoma
17
Ovarian Neoplasms
16
Colorectal Neoplasms
16
Recurrence
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Lymphoma
13
Myelodysplastic Syndromes
10
Uveal Melanoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Follicular
9
Head and Neck Neoplasms
9
Uterine Cervical Neoplasms
8
Multiple Myeloma
8
Congenital Abnormalities
8
Triple Negative Breast Neoplasms
7
Stomach Neoplasms
7
Lung Neoplasms
7
Hodgkin Disease
7
Squamous Cell Carcinoma of Head and Neck
6
Interventions
Sorafenib
68
Bevacizumab
44
Oxaliplatin
25
Doxorubicin
22
Gemcitabine
21
Fluorouracil
21
Radiosurgery
20
Nivolumab
19
durvalumab
18
Radiofrequency Ablation
18
pembrolizumab
17
lenvatinib
17
Cisplatin
17
Capecitabine
17
atezolizumab
14
Leucovorin
14
Hepatectomy
14
Radiotherapy
12
tremelimumab
10
Irinotecan
10
Drug Therapy
10
Cyclophosphamide
10
Carboplatin
10
Blood Specimen Collection
10
Ipilimumab
9
regorafenib
8
Liver Transplantation
8
Everolimus
8
Cryosurgery
8
Chemotherapy, Adjuvant
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Interleukin-2
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled